PureTech Health PLC 2020 AR2
The report highlights PureTech Health plc's clinical and financial milestones for the fiscal year 2020, including the successful listing of its American Depositary Shares on the Nasdaq Global Market. The company advanced multiple wholly-owned programs, initiating clinical trials for LYT-100 in Long COVID and lymphedema, and LYT-200 in metastatic solid tumors. Additionally, its founded entities achieved significant regulatory milestones, with FDA and EU clearances for Akili's EndeavorRx and Gelesis' Plenity. On the environmental front, the company reported a 72 percent reduction in total market-based greenhouse gas emissions compared to 2018 and moved into a LEED Silver certified headquarters.
Company: PureTech Health PLC
Sector: Professional & technical services
Country: United States
Year: 2020
Type: AR2
Pages: 232
Back to company
PureTech Health PLC
Annual Report And Accounts
The report highlights PureTech Health plc's clinical and financial milestones for the fiscal year 2020, including the successful listing of its American Depositary Shares on the Nasdaq Global Market. The company advanced multiple wholly-owned programs, initiating clinical trials for LYT-100 in Long COVID and lymphedema, and LYT-200 in metastatic solid tumors. Additionally, its founded entities achieved significant regulatory milestones, with FDA and EU clearances for Akili's EndeavorRx and Gelesis' Plenity. On the environmental front, the company reported a 72 percent reduction in total market-based greenhouse gas emissions compared to 2018 and moved into a LEED Silver certified headquarters.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Total Waste
Women on Board
Women in Management
Employees